Sergio Aguggini
Cremona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.
Journal: The oncologist
Published: February 18, 2024
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study.
Journal: Breast (Edinburgh, Scotland)
Published: October 18, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib.
Journal: Scientific reports
Published: February 22, 2023
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.
Journal: Frontiers in oncology
Published: March 27, 2021
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Journal: The American Journal of dermatopathology
Published: January 06, 2021
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 04, 2020
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials.
Journal: Breast (Edinburgh, Scotland)
Published: February 08, 2019
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR.
Journal: Journal of cancer research and clinical oncology
Published: December 10, 2017
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?
Journal: Future oncology (London, England)
Published: November 11, 2017
A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.
Journal: Future oncology (London, England)
Published: June 22, 2016
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: May 25, 2016
Last Updated: 09/26/2026